Provides a cloud-based EEG analysis platform, NeuroMatch®, that uses patented neural information analysis technologies to decode brain networks and generate automated, longitudinal diagnostic reports. By reducing artifacts, enabling 24-hour trending, and offering browser-based access with role-based controls, it improves the efficiency and accuracy of neurological disease diagnosis while addressing the shortage of neurologists and sub-optimal clinical workflows.
Funding
Funding not disclosed
Founders
Product
Problem
The increasing demand for neurological diagnosis and treatment is outpacing the capacity of the healthcare system, exacerbated by a shortage of neurologists and suboptimal clinical workflows. Traditional EEG analysis methods can be subjective, time-consuming, and prone to artifacts, potentially leading to delayed or inaccurate diagnoses.
Solution
LVIS Corporation's NeuroMatch® Access is a cloud-based platform that leverages patented neural information analysis technologies and artificial intelligence to streamline EEG diagnostics. The platform reduces artifacts in EEG signals and decodes brain networks to provide visualizations that assist in neurological disease diagnosis. NeuroMatch® Access offers automated, longitudinal diagnostic reports and 24-hour trending summaries, improving the efficiency and accuracy of neurological assessments. The browser-based access with role-based controls enhances collaboration among physicians, enabling quicker review and interpretation of EEG data for timely and effective patient care.
Target Audience
The primary users are neurologists, hospitals, and clinics seeking to modernize their diagnostic capabilities, improve clinical workflows, and enhance patient care through AI-driven EEG analysis.
Features
- Cloud-based SaaS platform for EEG diagnostics
- Patented neural information analysis technologies to decode brain networks
- AI-powered artifact reduction in EEG signals
- Automated, longitudinal diagnostic reports
- 24-hour trending summaries
- Browser-based access with role-based controls
- Visualization of brain networks to assist in neurological disease diagnosis
- Regulatory clearance in the United States and Korea